This Circulation article outlines key limitations of BNP testing in identifying early elevations in cardiac filling pressure. The findings demonstrate why normal biomarker results do not reliably exclude elevated LVEDP, reinforcing the need to complement biomarker-based assessment with direct physiologic measurement to avoid missed or delayed heart failure diagnosis.